Drug CategoryDrugIHD Dosing

Administration Timing Around HD Session

NSAIDsIbuprofenAVOID if possible; 300mg PO Q8HAdminister Anytime During HD

Molecular Weight    (Da)

Excreted Unchanged (%)Normal Half-Life (Hours)ESRD Half-Life (Hours)Plasma Protein Binding (%)Volume of Distribution (L/kg)Dialytic Plasma Clearance (ml/min)% Dialyzed
20612-3.2Unchanged990.15-0.1729.9-954-16.7 (low flux)


  • Antal E, Ce W, Brown B, et al. The influence of hemodialysis on the pharmacokinetics of ibuprofen and its major metabolites. The Journal of Clinical Pharmacology. 1986;26(3):184-190.
  • Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA, et al. Drug Prescribing in Renal Failure. Philadelphia: American College of Physicians;2007.
  • DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL: http://www.drugbank.ca/drugs/DB01050
  • Ochs H, Greenblatt D, Verburg-Ochs B. Ibuprofen kinetics in patients with renal insufficiency who are receiving maintenance hemodialysis. Arthritis and rheumatism. 1985;28(12):1430-1434.
  • Senekjian H, Lee C, Kuo T, Au D, Krothapalli R. Absorption and disposition of ibuprofen in hemodialyzed uremic patients. European journal of rheumatology and inflammation. 1983;6(2):155-62.